罗氟司特片在哪买的到？

The essence of COPD is a chronic inflammation of the airways, and its inflammatory characteristics are of great significance to research on the treatment of COPD. Roflumilast tablets, as a new anti-inflammatory drug, have good anti-inflammatory effects. Roflumilast is a long-acting inhibitor of selective phosphodiesterase type 4 (PDE-4) and has anti-inflammatory effects. Phosphodiesterases are a family of enzymes including at least 11 subtypes of enzymes that catalyze the decomposition of the messenger molecules cyclic adenosine monophosphate and/or cyclic guanosine monophosphate. Phosphodiesterase-4 is a major cyclic adenosine monophosphate metabolic enzyme in inflammatory and immune cells, and phosphodiesterase-4 inhibitors have broad anti-inflammatory activities including inhibiting the release of inflammatory mediators and inhibiting immune cell activation. In addition, phosphodiesterase-4 inhibitors have also been shown to have therapeutic effects in animal models of airway inflammation.

The European Union approved the marketing of roflumilast film tablets in July 2010 for the treatment of chronic obstructive pulmonary disease (COPD). Roflumilast film tablet is a selective phosphodiesterase 4 (PDE4) inhibitor and is the first new class of chronic obstructive pulmonary disease (COPD) treatment drug approved by the EU in more than a decade. Roflumilast film tablet is a once-daily oral tablet that must be combined with other bronchodilators. Roflumilast film tablet is suitable for the maintenance treatment of severe chronic obstructive pulmonary disease COPD (post-diastolic FEV1 less than 50% of the expected value) associated with chronic bronchitis in adult patients with a history of frequent exacerbations. Roflumilast film tablets, as a new type of drug for the treatment of chronic obstructive pulmonary disease COPD, are expected to be launched on the European market soon. The first countries to be launched will be Germany and the United Kingdom.

Where can I buy Roflumilast tablets?

Roflumilast film tablets are not marketed in China, so patients cannot purchase the drug in domestic pharmacies. It is understood that the current cost-effective roflumilast film tablets are 500μg*90 tablets and sell for about $2,850 per box. The price is not fixed due to factors such as exchange rate fluctuations. If patients want to know the specific price information of this drug, or want to purchase cost-effective roflumilast overseas, they can consult with domestic reliable overseas medical service companies (such as Medical Companion Travel).

The above is the introduction about roflumilast, I hope it can help everyone.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related hot articles